Legis Daily

Uterine Cancer Study Act of 2025

USA119th CongressS-2285| Senate 
| Updated: 7/15/2025
Lisa Blunt Rochester

Lisa Blunt Rochester

Democratic Senator

Delaware

Cosponsors (2)
Angela D. Alsobrooks (Democratic)Cory A. Booker (Democratic)

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill mandates the Secretary of Health and Human Services to conduct a comprehensive study on the link between chemical hair straighteners and uterine cancer. This study will be carried out in coordination with the Commissioner of Food and Drugs and the Director of the National Institutes of Health. The study is specifically tasked with investigating the increased incidence of uterine cancer among women of color , while also considering impacts on all racial and ethnic groups. It requires a review of existing research, disaggregation of results based on product components like dyes or perms, and an evaluation of whether the Food and Drug Administration should implement additional testing requirements for manufacturers of these products. The Secretary must submit a methodology description within 45 days, commence the study within 180 days, and complete the study and submit a report to Congress within two years of the Act's enactment.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 15, 2025

Latest Companion Bill Action

HR 119-4396
Introduced in House
Jul 15, 2025
Introduced in Senate
Jul 15, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • July 15, 2025

    Latest Companion Bill Action

    HR 119-4396
    Introduced in House


  • July 15, 2025
    Introduced in Senate


  • July 15, 2025
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health

Related Bills

  • HR 119-4396: Uterine Cancer Study Act of 2025

Uterine Cancer Study Act of 2025

USA119th CongressS-2285| Senate 
| Updated: 7/15/2025
This bill mandates the Secretary of Health and Human Services to conduct a comprehensive study on the link between chemical hair straighteners and uterine cancer. This study will be carried out in coordination with the Commissioner of Food and Drugs and the Director of the National Institutes of Health. The study is specifically tasked with investigating the increased incidence of uterine cancer among women of color , while also considering impacts on all racial and ethnic groups. It requires a review of existing research, disaggregation of results based on product components like dyes or perms, and an evaluation of whether the Food and Drug Administration should implement additional testing requirements for manufacturers of these products. The Secretary must submit a methodology description within 45 days, commence the study within 180 days, and complete the study and submit a report to Congress within two years of the Act's enactment.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jul 15, 2025

Latest Companion Bill Action

HR 119-4396
Introduced in House
Jul 15, 2025
Introduced in Senate
Jul 15, 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • July 15, 2025

    Latest Companion Bill Action

    HR 119-4396
    Introduced in House


  • July 15, 2025
    Introduced in Senate


  • July 15, 2025
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Lisa Blunt Rochester

Lisa Blunt Rochester

Democratic Senator

Delaware

Cosponsors (2)
Angela D. Alsobrooks (Democratic)Cory A. Booker (Democratic)

Health, Education, Labor, and Pensions Committee

Health

Related Bills

  • HR 119-4396: Uterine Cancer Study Act of 2025
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted